PAR1 Inhibition Vorapaxar as a Potential Therapeutic Approach in Chronic Thromboembolic Pulmonary Hypertension

被引：0
|
作者：
Sun, Lu [1 ,2 ]
Liu, Min [3 ]
Yang, Peiran [4 ,5 ,6 ,7 ,8 ]
Zhai, Zhenguo [3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, China Japan Friendship Hosp, Beijing, Peoples R China
[2] Dept Pulm & Crit Care Med, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol, State Key Lab Resp Hlth & Multimorbid, Beijing, Peoples R China
[5] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China
[6] Natl Ctr Resp Med, Beijing, Peoples R China
[7] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[8] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA5231
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension?
    Quarck, Rozenn
    Delcroix, Marion
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) : 842 - 845
  • [2] The therapeutic potential of NAMPT in protecting against chronic thromboembolic pulmonary hypertension
    Sun, Lu
    Liu, Jixiang
    Yang, Peiran
    Zhai, Zhenguo
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] VORAPAXAR PAR1 Receptor Antagonist Antiplatelet Therapy
    Goto, S.
    Serebruany, V.
    DRUGS OF THE FUTURE, 2011, 36 (02) : 101 - 113
  • [4] Chronic Thromboembolic Pulmonary Hypertension: the therapeutic assessment
    Simeone, Beatrice
    Maggio, Enrico
    Schirone, Leonardo
    Rocco, Erica
    Sarto, Gianmarco
    Spadafora, Luigi
    Bernardi, Marco
    D'Ambrosio, Luca
    Forte, Maurizio
    Vecchio, Daniele
    Valenti, Valentina
    Sciarretta, Sebastiano
    Vizza, Carmine Dario
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [5] PAR1 Inhibition with Vorapaxar Enhances Renal Function and Modulates Inflammation Mediators in Diabetic Nephropathy
    Bohovyk, Ruslan
    Kravtsova, Olha
    Lowe, Melissa
    Upadhyay, Gunjan
    Levchenko, Vladislav
    Halade, Ganesh
    Palygin, Oleg
    Staruschenko, Alexander
    HYPERTENSION, 2024, 81
  • [6] CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION - THERAPEUTIC INDICATIONS
    AZARIAN, R
    BRENOT, F
    SITBON, O
    PARENT, F
    PETITPRETZ, P
    MUSSET, D
    GRIMON, G
    DARTEVELLE, P
    SIMMONNEAU, G
    DUROUX, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1994, 87 (12): : 1709 - 1713
  • [7] Chronic Thromboembolic Pulmonary Hypertension-Therapeutic Options
    Seyfarth, Hans-Juergen
    Hammerschmidt, Stefan
    Gessner, Christian
    Halank, Michael
    Wirtz, Hubert
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2006, 2 (04) : 431 - 438
  • [8] Chronic thromboembolic pulmonary hypertension - a diagnostic and therapeutic update
    Stricker, Hans
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2016, 45 (03) : 195 - 199
  • [9] Balloon Pulmonary Angioplasty as a Therapeutic Option for Chronic Thromboembolic Pulmonary Hypertension
    Matsubara, Hiromi
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S141 - S141
  • [10] Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension
    Remy-Jardin, Martine
    Hutt, Antoine
    Remy, Jacques
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 43 (06) : 936 - 945
12345